SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-16-461692
Filing Date
2016-02-12
Accepted
2016-02-12 13:03:00
Documents
2
Group Members
ESSEX WOODLANDS HEALTH VENTURES VI, L.L.C.ESSEX WOODLANDS HEALTH VENTURES VI, L.P.IMMANUEL THANGARAJJAMES L. CURRIEJEFF HIMAWAN, PH.DMARTIN P. SUTTERPETRI VAINIO, MD, PH.D.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d124261dsc13da.htm SC 13D/A 133207
2 EX-99.1 d124261dex991.htm EX-99.1 10035
  Complete submission text file 0001193125-16-461692.txt   145016
Mailing Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037
Business Address 4275 EXECUTIVE SQUARE SUITE 650 LA JOLLA CA 92037 858-373-1500
MEDICINOVA INC (Subject) CIK: 0001226616 (see all company filings)

IRS No.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81409 | Film No.: 161417159
SIC: 2834 Pharmaceutical Preparations

Mailing Address 21 WATERWAY AVENUE SUITE 225 THE WOODLANDS TX 77380
Business Address 21 WATERWAY AVENUE SUITE 225 THE WOODLANDS TX 77380 2813648338
ESSEX WOODLANDS HEALTH VENTURES FUND VI L P (Filed by) CIK: 0001276801 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A